|
|
|||||||
 |
|
|
LinkBack | Thread Tools | Display Modes |
06-24-2010, 12:35 AM
|
|||
|
|||
FDA: Pfizer Voluntarily Withdraws Cancer Treatment Mylotarg From U.S. Market
Pfizer Inc. announced the voluntary withdrawal from the U.S. market of the drug Mylotarg (gemtuzumab ozogamicin) for patients with acute myeloid leukemia (AML), a bone marrow cancer. The company took the action at the request of the U.S. Food and Drug Administration after results from a recent clinical trial raised new concerns about the product's safety and the drug failed to demonstrate ...
    
|
|
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Pfizer Withdraws Mylotarg Cancer Treatment After Deaths, No Proven Benefit | cancerfr | Lung Cancer | 0 | 06-22-2010 06:49 AM |
| Pfizer to withdraw leukemia drug Mylotarg | cancerfr | Leukemia | 0 | 06-22-2010 06:49 AM |
| FDA: Pfizer Voluntarily Withdraws Cancer Treatment Mylotarg From U.S. Market | cancerfr | Liver Cancer | 0 | 06-22-2010 06:49 AM |
| FDA: Pfizer To Remove Cancer Drug Mylotarg From US Market | cancerfr | Liver Cancer | 0 | 06-22-2010 06:49 AM |
| Pfizer Withdraws Drug After Deaths, No Proven Benefit (Update1) | cancerfr | Liver Cancer | 0 | 06-22-2010 06:49 AM |
Linear Mode
